Skip to content

Draft, not yet released. In stewardship review. Not indexed until the first approved release.

कार्यप्रणाली

How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.

14 min read0 figures13 tables17 notesNR-XTECH-SYNBIO-GLOBAL-2026-BASELINE

विषय-सूची
  1. ·Edition home
  2. ·Executive summary
  3. 1Synthetic biology is a build capability and a governance test
  4. 2Key findings
  5. 3Systems and sectors at baseline
  6. 4Risks and capability
  7. 5Design capability outpaces screening and oversight
  8. 6Readings from the other desks
  9. 7The 2027 agenda
  10. 8Systems in depth
  11. Aकार्यप्रणाली
    1. A.1 Methods
    2. A.2 Model card, Synthetic biology System Model v0
    3. A.3 The baseline evidence cut
    4. A.4 Evidence age and coverage
    5. A.5 Evidence cards, two anchor sources
    6. A.6 Publication acceptance record
    7. A.7 Status words
    8. A.8 How the edition is made, released and corrected
    9. A.9 Glossary and abbreviations
    10. A.10 Technical annex
  12. BData appendix
  13. CReferences and record
  14. ·Complete edition, for print

A.1पद्धतियाँ

The global baseline uses published values and four simple derivations. Each is shown in full so that any reader can reproduce it.

Table A.1Methods
No.DerivationCalculationपरिणाम
(1)Fall in codons from the standard code to Syn5764 minus 577 codons
(2)Growth in recoded codons, Syn57 against Syn61 (lower bound)101,000 ÷ 18,214about 5.5 times
(3)Change in Ginkgo Bioworks revenue, 2024 to 2025(170.155 minus 227.043) ÷ 227.043about minus 25%
(4)Share of Twist Bioscience third-quarter revenue from DNA synthesis and protein solutions56.6 ÷ 118.4about 48%
Table A.2Coupling strength scale (matrix and model card)
Strengthपरिभाषा
STRONGa disruption in the source system has historically changed the target system’s service or output within one season, in more than one region
MODERATEan effect is documented but buffered or slower
WEAKan effect is plausible but not documented at global scale
Table A.3Status grammar
लेबलनियम
रिपोर्ट किया गयाvalue as issued by its source, with year
Inferredreasoned from cited evidence; never a measurement
अनुमानितNexus analytical value with stated method
परिदृश्यconditional on stated assumptions
Expert inputstructured editorial judgement awaiting evidence

A.2Model card, Synthetic biology System Model v0

Model ID
MDL-XT04-SYNBIO · v0.1
उद्देश्य
represent synthetic biology as a build capability and manufacturing base coupled to health, food, energy, feedstock, finance, workforce and biosecurity
परिवार
graph-based system of systems
इनपुट
the cited sources of this edition; no proprietary data
पद्धति
expert-specified coupling strengths (STRONG · MODERATE · WEAK) from assessments and analogue events
सत्यापन
none yet, first validation against federation evidence in 2027
अनिश्चितता
qualitative; strengths are hypotheses, not measurements
Domain of validity
global scale; not for asset-, site- or country-level use
पुनरुत्पादनीयता
strength table and sources published in this edition
20couplings

typed in v0

0strong

documented within one season

1moderate

documented, buffered

19weak

plausible, undocumented

A.3The baseline evidence cut

Every Nexus edition is published from a frozen evidence cut. The global baseline cut is documentary: it pins the exact edition of every source cited. Federation cuts begin with the first national Foundry cuts in 2027.

Cut ID
DC-XTECH-SYNBIO-GLOBAL-2026-B0
प्रकार
baseline documentary cut
Resolution policy
pinned · as of 30 September 2026
Sources pinned
44 cited sources, each at the edition and access date in the references
Model runs
none at baseline, analytical values are stated with their method
Digest
computed at freeze and recorded in the publication record
Supersedes
nothing, first cut of the series
Superseded by
the 2027 synthetic biology annual cut

वंशावली

  1. 01

    source edition

  2. 02

    pinned citation

  3. 03

    finding

  4. 04

    page

  5. 05

    publication record

Table A.4From the baseline cut to the federation cut
तत्वBaseline 20262027 global annual
स्रोतcited global publications, pinned by editionnational, regional and sector cuts through one graph
Analysisstated methods and editorial estimatestyped analysis specifications
मॉडलSynthetic biology System Model v0 specificationmodel runs with receipts
निष्कर्षtwelve baseline findingsfindings re-bound to federation evidence
समीक्षाfive passes scheduledfive passes on the exact digest

A.4Evidence age and coverage

A 2026 global edition rests on evidence observed in many different years. This page shows each time base, so that no single year label hides older evidence.

Table A.5Evidence age and coverage
संकेतकप्रेक्षितजारीलयNext release
Recoded genome results2019 to 2025Nature 2019 · Science Oct 2025one-offfollow-up papers
Synthetic yeast2023Cell Dec 2023one-offcompletion papers
Screening study2025Science Oct 2025one-offfollow-up studies
US commission report2025Apr 2025one-offlegislation
US screening framework2024 · 2025 orderApr 2024 · May 2025आवधिकreplacement text
EU Biotech Act2025Dec 2025आवधिकsecond act
OECD governance paper2026मई 2026one-offnext policy paper
Company results2025 to 2026Feb 2026 · Aug 2026त्रैमासिकnext earnings
Table A.6Coverage by system at baseline
प्रणालीकवरेजThinnest dimension
Build capabilityGOODindustrial-scale performance
ClinicalPARTIALlong-term outcomes
जैव सुरक्षाPARTIALscreening coverage
शासनPARTIALtext of replacement US framework
निवेशTHINcommon basis for public and private
Energy and feedstockTHINfermentation footprint
क्षमताTHINbiofoundry and plant counts
कौशलTHINworkforce numbers
Table A.7Designed empty states: what is not bound, what would fill it and why
क्षेत्रSource that would fill itBlocker
Energy, water and feedstock use of biomanufacturing at scaleproducers, national laboratories, peer-reviewed life-cycle studiesnot retrieved on a common basis; no study opened
DNA synthesis capacity and screening coverage by provider and countryproviders, industry consortia, national agenciesno consolidated series found; screening pages not opened
Status and text of the US screening framework after the 2025 orderOSTP and White House publications2526framework and order read; no replacement text published; CRS reported in September 2026 that the 2024 framework had not been updated27
European Commission text of the Biotech Act proposalEuropean Commission proposal COM(2025) 102228proposal text read from a national parliament copy; detail beyond the chapters cited not reviewed22
Status of the EU second Biotech ActEuropean Commission, European Parliament legislative train29announced only; the legislative train edition of 20 September 2026 gives a Q3 2026 indicative date and no proposal
Public and private investment in synthetic biology on one basisnational statistics, OECD, industry surveysnot retrieved; only two company filings used1617
Biofoundry and fermentation capacity by countryindustry and trade statisticsnot retrieved
Programme totals for the US distributed bioindustrial manufacturing awards after September 2024US manufacturing programme pages24the page read lists totals to September 2024 only
Bioeconomy size from a primary statistical sourcenational accounts, OECDonly a secondary commentary figure read15
Workforce size and skills gapsnational statistics, OECD, industry surveysnot retrieved; capability rung stays LISTED
Independent replication and viral-resistance tests of recoded strainspeer-reviewed papersnot found at evidence close
Long-term outcomes of engineered therapiestrial follow-up publicationsonly the cited trial and one case report read810
Mirror life risk assessment beyond the policy forumpeer-reviewed risk studiesonly the forum abstract read12
Capability rungs beyond guidance and planningagencies, operators, laboratoriesnot reviewed

A.5Evidence cards, two anchor sources

Published in Science 390 (2025) by Robertson and colleagues; news page of 1 August 2025. One-off. Role: binds BLD-001. Coverage: one organism in one laboratory line.

EVD-XT04-001

Escherichia coli with a 57-codon genetic code1

Published in Science 390 (2025). One-off study. Role: binds SEC-005. Coverage: screening tools and open design software; no sequence detail is reproduced here.

EVD-XT04-002

Strengthening nucleic acid biosecurity screening against generative protein design tools13

Table A.8Quality dimensions at baseline
DimensionEVD-XT04-001EVD-XT04-002
Completenessone organism; about 4 million base pairsa set of screening tools and design software
Timelinessnews page about 12 weeks before the journal datejournal publication in 2025
Revisionpreprint and journal versionspatches reported after testing
Method transparencymethods published in the paperdetails limited for security reasons
External validationpeer reviewpeer review

Evidence cards to follow in 2027

  • Robertson et al.1: viral resistance and replication
  • Science screening study13: follow-up on patches and coverage
  • US framework25: replacement text
  • European Commission28: proposal text

A.6Publication acceptance record

Editorial self-check at evidence close. Every applicable item carries a disposition; the remaining items are review, approval and deposit.

Table A.9Publication acceptance record
समूहक्षेत्रमदउत्तीर्णN/Aलंबित
D1Identity and scope8800
D2Source and data12912
D3Analysis and models12381
D4Findings and claims9801
D5Figures, tables, maps10622
D6Editorial and citations10802
D7Review and approval130013
D8Artefact and design12705
D9Registry and release9009

Publication gate

Conditions met
14 of 23 at evidence close
Blocking problems
none recorded
Open conditions
reviews, approval of the exact digest, deposit, registry pointer

Not applicable at baseline

Model runs
first runs in Q1 2027
मानचित्र
plates in Q2 2027
Waivers
कोई नहीं

A.7Status words

Table A.10The status every value carries
स्थितिइसका क्या अर्थ है
प्रेक्षितMeasured directly and published by the source.
रिपोर्ट किया गयाPublished statistics of an official or institutional source.
घोषितStated by the body concerned; not independently measured.
अनुमानितA Nexus estimate from cited evidence, with its method in Annex A.
मॉडल-आधारितProduced by a stated model from cited inputs.
InferredReasoned from cited evidence; not measured.
पूर्वानुमानA projection by the cited source.
SimulatedA simulation result under stated assumptions.
परिदृश्यA conditional statement under stated assumptions; never a prediction.
Expert inputExpert judgement, recorded with its basis.
CandidateProposed for a later edition; not yet evidence.
Evidence-quality levels (EQL 1 to 5) grade the source behind a value; they are not a score of the subject.

A.8How the edition is made, released and corrected

Every edition is built from a sealed evidence cut, reviewed under three keys, signed and deposited before any site shows it as published; corrections go to Nexus Standards as change proposals and feed the next cut.

चरणक्या होता हैस्रोत
01 Evidence arrives from the pillarsFoundry seals observations and indicator series, Universe hands over after-action and scenario findings, and contributions are screened at every gateway, including this site’s.
02 The cut is sealedOn the cut date the evidence is pinned under one identifier, so anyone can rebuild the edition from exactly what it was built on.
03 The edition is assembledThe edition is drafted from its template and content pack. Agents may draft; they never publish and never decide.
04 The keys turnAt the publisher of record the truth key comes first: every value is checked against its source or stated method before the meaning and capital keys turn. No edition moves on until every key has been turned by a named steward.
05 The gate opensA named approver releases one exact digest of the edition; any change after this point is a new version, never a silent edit.
06 Signed and depositedThe PDF, the web edition and the data bundle are signed together with a manifest and an RO-Crate description, and deposited on Zenodo with a concept and a version DOI.
07 Published on its desk’s siteOnly then does the edition show as published on its desk’s Reports site, and the Collection lists it as a part.
08 Corrections go to StandardsMethod and correction findings go to Nexus Standards as change proposals; citations, corrections and new contributions feed the next evidence cut.

A teaching model of the process, not a forecast and not a record of any run; dates and counts on this page come from the programme record. Sources: Reports governance at GCRI Canada (2026); Zenodo, repository of record for Reports deposits (2026).

Lifecycle, one state at a time: Draft, Computed, Evidence bound, Reviewed, Approved for release, Published, Corrected, Superseded. This edition is a draft.

A.9Glossary and abbreviations

Table A.11Series terms
शब्दअर्थ
Baseline Editionthe inaugural annual edition that fixes the reference state for the series
WEFH+Bwater, energy, food, health and biodiversity, the national nexus core
युग्मनa typed dependency through which one system transmits to another
संरक्षण अंतरालthe share of losses not covered by insurance
Capability ladderLISTED → EXISTS → ADEQUATE → TESTED → DEMONSTRATED
EQLevidence-quality level, 1–5
साक्ष्य निर्धारित सीमाa frozen resolution of exact sources and versions
NNC · NLC · NWGNational Nexus Consortium · National Leadership Council · National Working Groups
Table A.12Abbreviations used in this edition
AbbreviationExpansion
AHTEGAd Hoc Technical Expert Group
BWCजैविक हथियार अभिसमय
CBDजैविक विविधता पर अभिसमय
CRSCongressional Research Service
DBIMPDistributed Bioindustrial Manufacturing Program
EOexecutive order
FDAUS Food and Drug Administration
IGSCInternational Gene Synthesis Consortium
NSCEBNational Security Commission on Emerging Biotechnology
OECDOrganisation for Economic Co-operation and Development
OSTPOffice of Science and Technology Policy
SPCsupplementary protection certificate

A.10Technical annex

Table A.13Technical annex
मदAnnexविषय-सूचीस्थिति
A.1Indicator definitionsthe global indicator set, with units and sourcesIN THIS EDITION
A.2Coupling strengthsthe twenty-cell matrix and its rationaleIN THIS EDITION
A.3Scenario specificationSCN-XT04-DSG-01 assumptions and signpostsIN THIS EDITION
A.4Capability placementsrung evidence for fifteen functionsIN THIS EDITION
A.5Model diagnosticsfirst runs and validation2027
A.6Sensitivity analysesinfluence of coupling strengths2027
A.7Cluster notescards for the major platform, DNA supply and manufacturing clusters2027
A.8Review statementspass-by-pass review recordAT RELEASE

A.1 · indicator definition: codons recoded

Construct
number of codon positions in a genome replaced by a synonymous codon
इकाई
count of codons
पद्धति
genome design, fragment synthesis and assembly
स्रोत
Nature 569 (2019)3; Science 390 (2025) and the research institute news page2
अनिश्चितता
the Syn57 count is stated as over 101,000, a lower bound
ज्ञात सीमाएँ
counts may include sense codons and a stop codon; one lineage of organisms

Notes

Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references

  1. 25National Science and Technology Council, Fast Track Action Committee on Synthetic Nucleic Acid Procurement Screening (ed.), Framework for Nucleic Acid Synthesis Screening (version 1 April 2024, revised September 2024; framework document read). Office of Science and Technology Policy, Washington. Observation year 2024. Accessed 2026-11-05.back
  2. 26The White House (ed.), Executive Order 14292 of 5 May 2025, Improving the Safety and Security of Biological Research, Federal Register 2025-08266, 8 May 2025 (text read; section 4(b) gives OSTP 90 days to revise or replace the 2024 Framework for Nucleic Acid Synthesis Screening). Office of the Federal Register, Washington. Observation year 2025. Accessed 2026-11-05.back
  3. 27Congressional Research Service (ed.), Artificial Intelligence and Biosecurity Issues, CRS In Focus IF13269, 16 July 2026, updated 3 August and 15 September 2026 (all three versions read; the July version states that CRS could not determine whether the 2024 policy and the 2024 screening framework had been revised or replaced; the September update states that a July 2026 policy replaced the 2024 dual-use research policy and that OSTP had not updated the 2024 screening framework). Library of Congress, Washington. Observation year 2026. Accessed 2026-11-05.back
  4. 28European Commission (ed.), Proposal for a Regulation on establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health (European Biotech Act), COM(2025) 1022 final, 2025/0406 (COD), Strasbourg, 16 December 2025 (proposal text read from the copy transmitted to the Austrian Parliament; health biotechnology investment pilot with the European Investment Bank Group; 12-month extension of the supplementary protection certificate; chapter on biodefence and preventing biotechnology misuse). European Commission, Brussels. Observation year 2025. Accessed 2026-11-05.back
  5. 22Baker McKenzie (ed.), EU Biotech Act unveiled: Commission proposal to turn Europe into a biotech powerhouse (law firm summary, 19 December 2025; proposal of 16 December 2025; health focus; investment pilot with the European Investment Bank Group; 12-month certificate extension; biodefence measures; second act expected in Q3 2026). Secondary source, not the Commission text. Observation year 2025. Accessed 2026-11-03.back
  6. 29European Parliament (ed.), Legislative Train Schedule: European Biotech Act II (edition of 20 September 2026 read; status announced; Commission work programme 2026 indicative date Q3 2026; would broaden the health-focused Act I to industrial biotechnology and biomanufacturing). European Parliament, Brussels. Observation year 2026. Accessed 2026-11-05.back
  7. 16Twist Bioscience Corporation (ed.), Form 8-K exhibit 99.1, results for the fiscal third quarter ended 30 June 2026 (company filing; revenue USD 118.4 million; nine months USD 332.8 million; fiscal 2026 guidance USD 456 to 457 million; company statements and guidance are weak evidence). US Securities and Exchange Commission, Washington. Observation year 2026. Accessed 2026-11-03.back
  8. 17Ginkgo Bioworks Holdings, Inc. (ed.), Form 8-K exhibit 99.1, fourth quarter and full year 2025 results (company filing of 26 February 2026; revenue USD 170.155 million against USD 227.043 million; net loss USD 312.763 million; company statements are weak evidence). US Securities and Exchange Commission, Washington. Observation year 2025. Accessed 2026-11-03.back
  9. 24US Manufacturing Program (ed.), Bioindustrial (programme topic page; Distributed Bioindustrial Manufacturing Program awards announced 10 July to 13 September 2024; 25 awards; USD 42 million cumulative). Manufacturing USA, Gaithersburg. Observation year 2024. Accessed 2026-11-03.back
  10. 15Federation of American Scientists (ed.), Translating Vision into Action: FAS commentary on the NSCEB final report (commentary page; six pillars; cites over USD 210 billion of US GDP and over 640,000 jobs for the bioeconomy; secondary and advocacy-leaning source). Federation of American Scientists, Washington. Observation year 2025. Accessed 2026-11-03.back
  11. 8Frangoul, H. et al., Exagamglogene autotemcel for severe sickle cell disease, New England Journal of Medicine 390 (18), 1649 to 1662, 2024 (record read via Europe PMC: 44 treated; 29 of 30 evaluable free of severe crises for 12 months; median follow-up 19.3 months). Massachusetts Medical Society, Waltham. Observation year 2024. Accessed 2026-11-03.back
  12. 10Musunuru, K. et al., Patient-specific in vivo gene editing to treat a rare genetic disease, New England Journal of Medicine 392 (22), 2235 to 2243, 2025 (record read via Europe PMC: one infant; two infusions at about 7 and 8 months). Massachusetts Medical Society, Waltham. Observation year 2025. Accessed 2026-11-03.back
  13. 12Confronting risks of mirror life, Science 386, 1351 to 1353, 2024 (record read via Europe PMC; the record gives only a one-line abstract calling for broad discussion). American Association for the Advancement of Science, Washington. Observation year 2024. Accessed 2026-11-03.back
  14. 1Robertson, W.E. et al., Escherichia coli with a 57-codon genetic code, Science 390 (6771), eady4368, published 23 October 2025 (record read via PubMed, PMID 40743368; the record gives a 4 megabase synthetic genome and six replaced sense codons). American Association for the Advancement of Science, Washington. Observation year 2025. Accessed 2026-11-03.back
  15. 13Strengthening nucleic acid biosecurity screening against generative protein design tools, Science 390 (6768), 82 to 87, 2025 (record read via Europe PMC; abstract only; no method detail used). American Association for the Advancement of Science, Washington. Observation year 2025. Accessed 2026-11-03.back
  16. 3Fredens, J. et al., Total synthesis of Escherichia coli with a recoded genome, Nature 569 (7757), 514 to 518, 2019 (record read via Europe PMC: 18,214 codons recoded; 61-codon genome). Springer Nature, London. Observation year 2019. Accessed 2026-11-03.back
  17. 2MRC Laboratory of Molecular Biology (ed.), Syn57 represents a new chapter in the genetic code of life (news page, 1 August 2025; over 101,000 codons recoded; 64 to 57 codons; genome of about 4 megabases built from 38 fragments of about 100 kilobases). MRC Laboratory of Molecular Biology, Cambridge. Observation year 2025. Accessed 2026-11-03.back

Downloads

Draft, not yet releasedReview copies of a draft in stewardship review. The released edition carries its DOI and replaces them.

  • प्रिंट करें

    • PDF, A4

      The designed print edition, A4: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF116 pages1.1 MBTagged, with bookmarks

      SHA-256 639c56cefb1949003c7c12afb373872ca06a7a9d2636ed3a03036421f5a0667e

    • PDF, US Letter

      The designed print edition, US Letter: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF124 pages1.1 MBTagged, with bookmarks

      SHA-256 809ea48a7122779a508bafef6382f20f37c4aec32bc811e35c132e78757714e8

  • Web edition

  • डेटा बंडल

    • Indicators, CSV

      21 indicators with unit, year, status and source

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE-indicators.csv2 KB

      SHA-256 ad80b1f5ddbd91cc3df1a06ae20fc038c8db1504b94d5d927e92cf4654cd1ef9

    • Indicators, JSON

      The same indicators with the edition’s identity and licence

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE-indicators.json3 KB

      SHA-256 42ed0ca7518f347165dbd95fe4869ad99cc319a622d910a46b91989f1f5b7e08

    • Findings, CSV

      12 findings with status, evidence-quality level and references

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE-findings.csv4 KB

      SHA-256 1adaa8152308fb73ac5dd085a986cd24ce190e4728716aa4ff4a1b50a4e68f87

  • Citation files

    • Citation, BibTeX

      For LaTeX and reference managers

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE.bib1 KB

      SHA-256 ea099771745b82b9d4f32643f1660d265a4d736b13c87edd7f1d406f3f019d07

    • Citation, RIS

      For Zotero, EndNote and Mendeley

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE.ris1 KB

      SHA-256 17ed68ee662c0db11b3426eaeb65535f5fd14473a85160734886ccf70a44423b

    • Citation, CITATION.cff

      Citation File Format 1.2.0, for GitHub, Zenodo and software catalogues

      NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE.cff1 KB

      SHA-256 0b1b02fec9505a958f1baaab6932ca483182ef925f5b68fadb22734159e1daea

Check a file with its SHA-256: shasum -a 256 <file> (macOS, Linux) or Get-FileHash <file> (Windows). Text, tables and figures by Nexus: CC BY 4.0; each source keeps its own licence.

Cite this annex

Valadbaygi, S. (Ed.). (2026). Annex A: Methodology. In Exponential Technology Report 2026: Synthetic Biology and Bioengineering (Baseline Edition 2026, Report No. NR-XTECH-SYNBIO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI).

Every citation form of the whole report, BibTeX and RIS included, is on the edition home. Cite this report

रिपोर्टयोगदान दें

Send evidence or a correction on Synthetic Biology and Bioengineering.

Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the Global Centre for Risk and Innovation (GCRI) Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.

GCRI प्रणाली साक्ष्य डेस्कघातांकीय प्रौद्योगिकी
Contribution form · reports.contribution.gcri

व्यक्तिगत डेटा, संवेदनशील अवसंरचना का विवरण या ऐसी कोई भी सामग्री कभी न भेजें जिसे साझा करने का आपको अधिकार नहीं है। उपयोग से पहले योगदान की समीक्षा होती है; इसे भेजने से लेखकत्व या संपादकीय अधिकार नहीं मिलते, और प्रायोजन कभी किसी निष्कर्ष को नहीं खरीदता।

CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.